PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
25-Sep-2024 Quell Therapeutics expands manufacturing capabilities for CAR-Treg cell therapy pipeline through partnership with eXmoor pharma Quell Therapeutics
25-Sep-2024 Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments The Oxford-Harrington Rare Disease Centre
25-Sep-2024 AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy AlgoTherapeutix
25-Sep-2024 Explosive Growth in 3D Imaging Market Driven by Advancements in Healthcare and Industrial Applications Acumen Research And Consulting
24-Sep-2024 Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider Phastar
24-Sep-2024 Digital Therapeutics Market To Witness Explosive Growth of Around 29% CAGR from 2023 to 2032 Driven By Widespread Adoption of Digital Health Solutions Acumen Research And Consulting
24-Sep-2024 Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs Mabylon AG
23-Sep-2024 Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Vicebio Ltd
23-Sep-2024 Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Sanofi
23-Sep-2024 Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering Zenas BioPharma
23-Sep-2024 Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant Sanofi
23-Sep-2024 Biocomposites to showcase innovations in infection management at EBJIS 2024 Biocomposites
23-Sep-2024 Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia Teva Pharmaceutical Industries Ltd
23-Sep-2024 Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis AstraZeneca
23-Sep-2024 Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East Ondine Biomedical Inc
23-Sep-2024 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA Association of the British Pharmaceutical Industry (ABPI)
23-Sep-2024 Terumo Blood and Cell Technologies collaborates with Nova Biomedical to bring automated cell culture sensing to Quantum Flex Terumo Blood and Cell Technologies
23-Sep-2024 European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement The European Microbiome Innovation for Health
23-Sep-2024 Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Theriva™ Biologics, Inc.
23-Sep-2024 ABPI welcomes Chancellor’s speech at Labour party conference ABPI